Characterizing Deep Quality-of-Life Response in the TRuE-V1/TRuE-V2 Studies of Ruxolitinib Cream in Nonsegmental Vitiligo. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 10, n. 2, p. s752, 2026. DOI: 10.25251/bpnxm492. Disponível em: https://skin.dermsquared.com/skin/article/view/4072. Acesso em: 2 may. 2026.